Uzbekistan Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Uzbekistan Health News.

Press releases published on October 15, 2026

3 hours ago

Paretofit Announces Founder Tobias Burkhardt's Feature in Prime Today on Sustainable Performance for Entrepreneurs

Indeterminate GlobeNewswire

3 hours ago

Conexeu Sciences Announces $5 Million Private Placement Led by Existing Shareholders, Management and Directors

Indeterminate GlobeNewswire

3 hours ago

Freenome to Report Third Quarter 2026 Financial Results on November 10, 2026

Indeterminate GlobeNewswire

3 hours ago

Crescent Biopharma Announces Clinical Pipeline Momentum, including Enrolling Patients in Standard of Care Chemotherapy Combination Cohorts of Global Phase 1/2 ASCEND Trial of CR-001, a PD-1 x VEGF Bispecific Antibody, and Initiation of Additional ADC…

Indeterminate GlobeNewswire

3 hours ago

LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026

Indeterminate GlobeNewswire

3 hours ago

Full 12-Month Data from the ACCCESS U.S. Pivotal Study in Complete Concentric Collapse Patients Presented at ISSS 2026

Indeterminate GlobeNewswire

3 hours ago

Données Complètes à 12 Mois de l’Étude Pivot Américaine ACCCESS chez les Patients Atteints de Collapsus Concentrique Complet Présentées à l’ISSS 2026

Indeterminate GlobeNewswire

3 hours ago

Mobia Medical to Report Third Quarter 2026 Financial Results on November 5, 2026

Indeterminate GlobeNewswire

3 hours ago

Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference

Indeterminate GlobeNewswire

3 hours ago

Myriad Genetics to Release Third Quarter 2026 Financial Results on November 4, 2026

Indeterminate GlobeNewswire

3 hours ago

LB Pharmaceuticals to Participate in Upcoming Investor Events

Indeterminate GlobeNewswire

3 hours ago

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

3 hours ago

MacroGenics Announces First Patient Dosed in Phase 1 Study of MGC030 in Patients with Advanced Solid Tumors

Indeterminate GlobeNewswire

3 hours ago

Syndax’s Revuforj® (revumenib) Named to TIME’s Best Inventions of 2026 List

Indeterminate GlobeNewswire

3 hours ago

MDxHealth Announces Preliminary Third Quarter 2026 Revenue and Suspends Full-Year 2026 Revenue Guidance

Indeterminate GlobeNewswire

3 hours ago

Opus Genetics Presents Positive Clinical Data from OPGx-BEST1 and OPGx-LCA5 Gene Therapy Programs at Retina in Rio 2026

Indeterminate GlobeNewswire

3 hours ago

Anavex Receives FDA Clearance of its IND Application for Blarcamesine in Fragile X Syndrome

Indeterminate GlobeNewswire

4 hours ago

Avance Clinical to Showcase its Early Phase Center of Excellence Model at AusBiotech International 2026

Indeterminate GlobeNewswire

6 hours ago

Grupo Bimbo Achieves 98% Positive Nutrition Across Its Daily Consumption Portfolio

Indeterminate GlobeNewswire

7 hours ago

Booking Health Announces Medical Records Review, Specialist Second Opinions and Treatment Coordination for Pancreatic Cancer Patients Seeking Care in Germany

Indeterminate GlobeNewswire